FOUNDER(S)
Chanho Lim
Aitria is an AI-powered ECG analysis platform designed to assist clinicians in evaluating the treatment effects for AF patients, particularly in determining the likelihood of AFib recurrence and the potential need for re-ablation. The platform processes patient-submitted ECG data. We then apply proprietary classification models, and generate predictive insights. Aitria is device-agnostic, supporting ECG data from Smartwatches and other single-lead ECG devices.
Why Startup Team Mentoring? “We joined the Startup Team Mentoring program because its multidisciplinary mentor bench—spanning digital health venture building, cloud architecture, clinical research, and FDA SaMD regulation—perfectly matches Aitria’s growth priorities. Over the next six months, we aim to (1) pressure-test and sharpen our B2B SaaS pricing and go-to-market plan, (2) stress-proof our data-handling pipeline for scale and HIPAA/GDPR compliance, (3) map a clear 510(k) pre-submission → clearance pathway with expert regulatory guidance, and (4) refine our clinical-evidence roadmap to support reimbursement and commercialization. We also hope to tap the mentors’ fundraising experience—especially around non-dilutive grants and seed capital—to accelerate product validation milestones. Ultimately, the program’s collective wisdom will help us transform Aitria from a robust prototype into a clinically trusted, revenue-generating platform that extends the benefits of ablation therapy by catching atrial-fibrillation recurrence early and guiding timely re-intervention.”
Mentorship Team: Lee Chedister, Jeremy Reimann, Neal Muni, Soumitra Sengupta, Joel Kanter
